Remodelling of the Cardiac Extracellular Matrix: Role of Collagen Degradation and Accumulation in Pathogenesis of Heart Failure

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-3-319-17437-2_12
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical outcome, echocardiographic assessment, neurohormonal and collagen turnover markers in low-fl ow severe aortic stenosis with high transvalvular gradient.

  2014cited by this paper
• Fibrosis and heart failure

  2014cited by this paper
• Fibroblasts in myocardial infarction: a role in inflammation and repair.

  2014cited by this paper
• Matrix as an Interstitial Transport System

  2014cited by this paper
• Metalloproteases meprin α and meprin β are C- and N-procollagen proteinases important for collagen assembly and tensile strength

  2013cited by this paper
• Stem cell transplantation as a therapy for cardiac fibrosis

  2013cited by this paper
• Circulating biomarkers of collagen type I metabolism mark the right ventricular fibrosis and adverse markers of clinical outcome in adults with repaired tetralogy of Fallot.

  2013cited by this paper
• A novel heart failure mice model of hypertensive heart disease by angiotensin II infusion, nephrectomy, and salt loading.

  2013cited by this paper
• Myofibroblast-mediated mechanisms of pathological remodelling of the heart

  2013cited by this paper
• Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis.

  2013cited by this paper
• Procollagen C-proteinase enhancer grasps the stalk of the C-propeptide trimer to boost collagen precursor maturation

  2013cited by this paper
• Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression.

  2013cited by this paper
• Membrane-associated matrix proteolysis and heart failure.

  2013cited by this paper
• Matrix metalloproteinases: drug targets for myocardial infarction.

  2013cited by this paper
• Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.

  2013cited by this paper
• Pathological Ventricular Remodeling: Mechanisms Part 1 of 2

  2013cited by this paper
• Integrating the myocardial matrix into heart failure recognition and management.

  2013cited by this paper
• Fibrosis and mortality in patients with dilated cardiomyopathy.

  2013cited by this paper
• Mechanisms of fibrosis: therapeutic translation for fibrotic disease

  2012cited by this paper
• Ubiquitin-dependent regulation of COPII coat size and function

  2012cited by this paper
• Tissue inhibitor of metalloproteinases (TIMPs) in heart failure

  2012cited by this paper
• Animal models of heart failure: a scientific statement from the American Heart Association.

  2012cited by this paper
• Effects of the absence of procollagen C-endopeptidase enhancer-2 on myocardial collagen accumulation in chronic pressure overload.

  2012cited by this paper
• Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease

  2012cited by this paper
• Impact of Progression of Diastolic Dysfunction on Mortality in Patients With Normal Ejection Fraction

  2012cited by this paper
• Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

  2012cited by this paper
• Matricellular proteins in cardiac adaptation and disease.

  2012cited by this paper
• Matrix Metalloproteinase-28 Deletion Amplifies Inflammatory and Extracellular Matrix Responses to Cardiac Aging

  2011cited by this paper
• The prognostic value of circulating markers of collagen turnover after acute myocardial infarction.

  2011cited by this paper
• SPARC regulates collagen interaction with cardiac fibroblast cell surfaces.

  2011cited by this paper
• Fibroblasts and Myofibroblasts: What Are We Talking About?

  2011cited by this paper
• Procollagen C-proteinase Enhancer Stimulates Procollagen Processing by Binding to the C-propeptide Region Only

  2011cited by this paper
• Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction

  2011cited by this paper
• Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice

  2011cited by this paper
• Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association

  2011cited by this paper
• Cellular/extracellular matrix cross‐talk in scar evolution and control

  2011cited by this paper
• Potential Therapeutic Targets for Cardiac Fibrosis: TGF&bgr;, Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation

  2010cited by this paper
• Non-fibrillar collagens: key mediators of post-infarction cardiac remodeling?

  2010cited by this paper
• Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics.

  2010cited by this paper
• Extracellular matrix fibrotic markers in heart failure

  2010cited by this paper
• Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

  2010cited by this paper
• Myocardial remodeling after infarction: the role of myofibroblasts

  2010cited by this paper
• Matrix metalloproteinase proteomics: substrates, targets, and therapy.

  2009cited by this paper
• Pressure Overload–Induced Alterations in Fibrillar Collagen Content and Myocardial Diastolic Function: Role of Secreted Protein Acidic and Rich in Cysteine (SPARC) in Post–Synthetic Procollagen Processing

  2009cited by this paper
• Simultaneous Transforming Growth Factor β-Tumor Necrosis Factor Activation and Cross-talk Cause Aberrant Remodeling Response and Myocardial Fibrosis in Timp3-deficient Heart*

  2009cited by this paper
• New regulatory mechanisms of TGF-beta receptor function.

  2009cited by this paper
• Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction

  2009cited by this paper
• Cardiac myofibroblast differentiation is attenuated by alpha(3) integrin blockade: potential role in post-MI remodeling.

  2009cited by this paper
• Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.

  2008cited by this paper
• Macrophage roles following myocardial infarction.

  2008cited by this paper
• Cellular and molecular mechanisms of fibrosis

  2008cited by this paper
• Secreted Frizzled Related Protein 2 is a procollagen C proteinase enhancer with a role in myocardial infarction-associated fibrosis

  2008cited by this paper
• TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta.

  2008cited by this paper
• Bone marrow‐derived myofibroblasts contribute functionally to scar formation after myocardial infarction

  2008cited by this paper
• Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship.

  2008cited by this paper
• Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction

  2008cited by this paper
• The role of TGF-β Signaling in Myocardial Infarction and Cardiac Remodeling

  2007cited by this paper
• TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA

  2007cited by this paper
• The myofibroblast: one function, multiple origins.

  2007cited by this paper
• Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice.

  2007cited by this paper
• Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

  2007cited by this paper
• Collagens at a glance

  2007cited by this paper
• The relation between serum level of amioterminal propeptide of type I procollagen and diastolic dysfunction in hypertensive patients without diabetes mellitus: a pilot study

  2006cited by this paper
• The relation of amino-terminal propeptide of type III procollagen and severity of coronary artery disease in patients without myocardial infarction or hibernation.

  2006cited by this paper
• Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice

  2006cited by this paper
• Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events

  2006cited by this paper
• Fibrosis in heart disease: understanding the role of transforming growth factor‐β1 in cardiomyopathy, valvular disease and arrhythmia

  2006cited by this paper
• BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein

  2006cited by this paper
• Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.

  2005cited by this paper
• Angiotensin II and the Endothelium: Diverse Signals and Effects

  2005cited by this paper
• Combination of Tumor Necrosis Factor-α Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice

  2005cited by this paper
• Structural and functional characterisation of cardiac fibroblasts.

  2005cited by this paper
• Minoxidil exerts different inhibitory effects on gene expression of lysyl hydroxylase 1, 2, and 3: implications for collagen cross-linking and treatment of fibrosis.

  2005cited by this paper
• Expression analysis of the entire MMP and TIMP gene families during mouse tissue development

  2004cited by this paper
• Osteopontin Modulates Myocardial Hypertrophy in Response to Chronic Pressure Overload in Mice

  2004cited by this paper
• Alterations of Arterial Physiology in Osteopontin-Null Mice

  2003cited by this paper
• Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways.

  2003cited by this paper
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

  2003cited by this paper
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

  2003cited by this paper
• The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): differential effects on the hydroxylation of lysine in collagens I and II revealed by analysis of cross-linked telopeptides from urine.

  2002cited by this paper
• Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients

  2002cited by this paper
• Stimulation of Collagen Production by Transforming Growth Factor-&bgr;1 During Differentiation of Cardiac Fibroblasts to Myofibroblasts

  2002cited by this paper
• TIMP-1: A Marker of Left Ventricular Diastolic Dysfunction and Fibrosis in Hypertension

  2002cited by this paper
• PCOLCE2 Encodes a Functional Procollagen C-Proteinase Enhancer (PCPE2) That Is a Collagen-binding Protein Differing in Distribution of Expression and Post-translational Modification from the Previously Described PCPE1*

  2002cited by this paper
• The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis

  2001cited by this paper
• Exaggerated Left Ventricular Dilation and Reduced Collagen Deposition After Myocardial Infarction in Mice Lacking Osteopontin

  2001cited by this paper
• Induction of cardiac fibrosis by aldosterone.

  2000cited by this paper
• Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction.

  2000cited by this paper
• Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

  2000cited by this paper
• Angiotensin II, adhesion, and cardiac fibrosis.

  2000cited by this paper
• Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.

  2000cited by this paper
• Defining diastolic heart failure: a call for standardized diagnostic criteria.

  2000cited by this paper
• Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES)

  2000cited by this paper
• Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones.

  1999cited by this paper
• Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis.

  1999cited by this paper
• Importance of the basement membrane protein SPARC for viability and fertility in Caenorhabditis elegans.

  1998cited by this paper
• Abnormalities of the extracellular degradation of collagen type I in essential hypertension.

  1998cited by this paper
• Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling

  1997cited by this paper
• Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.

  1997cited by this paper
• Collagens: molecular biology, diseases, and potentials for therapy.

  1995cited by this paper

• No citing papers are available for this paper.